<p>Geron Corporation announced it will release its fourth quarter and full year 2025 financial results and business highlights before the market opens on Wednesday, February 25, 2026. Results will be available on the Investors and Media section of the Company’s website. A conference call and webcast will be held at 8:00 a.m. Eastern Time, with a live and archived audio webcast accessible from the Investors and Media section of the Company’s website (here). Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Geron Corporation published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9652858-en) on February 11, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)</p>

ARKG

Reuters

Invesco Biotechnology & Genome ETF

Ark Genomic Revolution ETF

VanEck Biotech ETF

ALPS Medical Breakthrough

VG Health

Health Care Select Sector SPDR

SPDR S&P Biotech

iShares US Pharma

Geron

First Trust NYSE Arca Biotech Index Fd

Proshares Ultra Nasdaq Biotech

iShares Biotechnology ETF

Geron Corporation to Announce Fourth Quarter and Full Year 2025 Financial Results